TiGenix NV — Form D
TiGenix NV of LEUVEN, C9, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-09. The offering totals $195K, of which $26K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-09
- Form: D
- Accession: 0000950103-18-000267
- Industry: Biotechnology
- Exemptions: 06b, 4a5
- Total offering: $195K
- Amount sold: $26K
- Remaining: $170K
- Investors: 2
- Date of first sale: 2017-11-16
- Security types: equity
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-302735
Issuer
- Name: TiGenix NV
- CIK: 0001581987
- Entity type: Corporation
- Jurisdiction: BELGIUM
- Address: ROMEINSE STRAAT 12 BOX 2, 3001, LEUVEN, C9, 3001
- Phone: +32 16 39 79 37
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| June Almenoff | Director | Tel Aviv, L3 |
| Eduardo Bravo Fernandez de Araoz | Director | Leuven, C9 |
| Willy Duron | Director | Leuven, C9 |
| Russell Greig | Director | Ness Ziona, L3 |
| Jean Stephenne | Director | Leuven, C9 |
| Eduardo Bravo Fernandez de Araoz | Executive Officer | Leuven, C9 |
| Wilfried Dalemans | Executive Officer | Leuven, C9 |
| Claudia D'Augusta | Executive Officer | Leuven, C9 |
| Marie Paule Richard | Executive Officer | Leuven, C9 |
| Guido Schopen | Executive Officer | Leuven, C9 |
| Maria Dolores Pascual Martinez | Executive Officer | Madrid, U3 |
| Eduardo Bravo | Director | Leuven, C9 |
| Eduardo Bravo | Executive Officer | Leuven, C9 |
Other filings by this issuer (1)
More